Biotechnology News Pheochromocytoma Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-5 out of 5 found

Current Search: pheochromocytoma: 5

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogen
Jimenez C et al.

- This study provides evidence that targeting tyrosine kinase receptors such as, vascular endothelial growth factor pathway and the platelet derived growth factor-(beta) receptor may have value in the treatment of VHL...

MDLinx: Nov 20 2008 4:03PM
Matching: pheochromocytoma

Find similar documents

Pheochromocytoma imaging with an unremarkable biochemical evaluation
Patient is a 65-year-old white man with a past medical history significant for severe coronary artery disease, arrhythmias, hypertension, hyperlipidemia, anxiety and type 2 diabetes.

He was referred to the endocrine clinic for the...

Endocrine Today: Nov 10 2008 5:28PM
Matching: pheochromocytoma

Find similar documents

Pheochromocytoma: Reports outline pheochromocytoma study findings from National Institute of Child Health and
(NewsRx.com) -- New investigation results, 'Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma,' are detailed...

NewsRX: Nov 4 2008 9:29PM
Matching: pheochromocytoma

Find similar documents

Increased carotid intima-media thickness in patients with pheochromocytoma in comparison to essential hyperten
Catecholamines due to various mechanisms may contribute to the accumulation of collagen fibers and extracellular matrix in the arterial wall.

The aim of this study was to compare intima-media thickness (IMT) of the common carotid artery ...

Nature: Oct 30 2008 11:23AM
Matching: pheochromocytoma

Find similar documents

FDA Approves GE Healthcare's AdreView (Iobenguane I 123 Injection) Diagnostic Agent for Detecting Neuroendocri
- GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced that the Food and Drug Administration (FDA) has approved AdreView(TM) (Iobenguane I 123 Injection), a molecular imaging agent for the detection of rare...

Pharma Live: Sep 19 2008 7:02PM
Matching: pheochromocytoma

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.